Loblaw Companies Ltd. Shareholders Are Lucky Nobody Cares About Customer Service

A recent trip to a Boston CVS Health Corp. (NYSE:CVS) drug store reminded me just how bad my local Shoppers Drug Mart is.

| More on:

My wife and I recently spent a weekend in downtown Boston. Having forgotten my allergy pills at home in Toronto, we made a beeline for the closest drugstore, which just happened to be a two-floor CVS Health Corp. (NYSE:CVS) right in the heart of Back Bay.

Upon walking in, we were immediately greeted with a warm welcome from a store employee who was out on the floor standing adjacent to the entrance. He was one of the several employees wandering both floors making sure customers got what they came for.

After greeting us, he asked if we were looking for anything in particular. I mentioned I’d forgotten my allergy pills. Without hesitating or having to look it up, he said, “Second floor, aisle 11.” If he wasn’t assigned the front door, I’m sure he would have taken us there personally.

As we rode the escalator to the second floor, we both remarked how cool it was to get that kind of service from a drug store — especially from one that’s part of a massive, faceless retail chain.

Non-existent service

You see, where we live in Leaside, a Toronto neighbourhood, our local Shoppers Drug Mart provides customer service that literally moves at a snail’s pace.

It doesn’t matter what time a day you go in to the store; there’s inevitably a lineup to pay at the cash. And God help you if you need to get someone to help find something. It’s virtually impossible.

Yet the business media has some of the most complimentary things to say about Shoppers’ parent, Loblaw Companies Ltd. (TSX:L) — myself included.

Praise for Loblaw

As someone who writes about stocks on both sides of the border, I couldn’t help but praise Loblaw in my April 14 article about its fantastic free cash flow generation.

“Since Galen Weston closed the deal to buy Shoppers Drug Mart in March 2014, Loblaw’s free cash flow has grown four-fold to $2.3 billion,” I wrote. “Before Shoppers, a $1.3 billion expenditure [how much the company is spending in fiscal 2017 on new stores and renovations of existing ones] would have eliminated its free cash flow almost entirely. Now, it represents just 37% of its annual operating cash flow.”

I too am hopelessly enamoured by Loblaw’s ability to generate excess cash: the cornerstone of any successful business.

Other Fool.ca contributors are equally enthusiastic.

Recently, Fool.ca’s Demetris Afxentiou called it a defensive play for any portfolio. His arguments for owning Loblaw stock ring true. However, it was his comments about Shoppers Drug Mart that caught my attention:

“One advantage that Loblaw has over the competition is the network of Shoppers Drug Mart stores. These pharmacy stores are much smaller than the typical Loblaw store, but they provide nearly the same level of national coverage,” Afxentiou wrote. “Loblaw has placed selected grocery products in Shoppers locations, thereby creating another option for consumers that need a few items on the way home who would rather not go to a larger grocery store.”

There’s no question that the 2014 acquisition transformed Loblaw’s business.

Thankfully, investors care little about customer service

After my CVS experience, which I realize might have been an aberration, I’m more likely to consider CVS stock.

As for Loblaw, this apparent gap in service has led me to reconsider whether I should buy its stock. Free cash flow or not, I believe good customer service is a reliable indicator of future financial performance.

The average investor might not care about service levels at Loblaw or its drugstore subsidiary, but I do.

Until I see a marked improvement at Shoppers Drug Mart stores (it’s not just the one on Bayview that’s poorly run), I’m hesitant to recommend Loblaw stock.

Bottom line on Loblaw stock

If you own Loblaw, I wouldn’t sell.

However, if you don’t, you might want to visit some Shoppers Drug Marts before investing your hard-earned dollars in its stock. If you feel the service isn’t an issue (it’s possible I’m too picky), buy away.

But if you don’t feel it’s up to snuff, find yourself another target, because there are a lot of worse things in life than sitting in cash.

Fool contributor Will Ashworth has no position in any stocks mentioned.

More on Investing

chart reflected in eyeglass lenses
Stocks for Beginners

3 TSX Stocks to Buy if You Think the TSX Stays Resilient

These three TSX stocks mix steady demand and growth potential across insurance, healthcare, and energy services.

Read more »

dividends grow over time
Dividend Stocks

Got $10,000? This Dividend Stock Could Deliver $44.26 a Month in Passive Income

You can turn $10K into an easy $44.26/month passive-income stream with this rock-solid Canadian REIT that's raised its payout for…

Read more »

warehouse worker takes inventory in storage room
Tech Stocks

3 Stocks I Loaded Up on Last Year for Long-Term Wealth

Understand the impact of recent geopolitical shifts on stocks and how they may influence future markets and generate wealth for…

Read more »

financial chart graphs and oil pumps on a field
Energy Stocks

3 Canadian Energy Stocks Heating Up for a Big Year

Do you want some exposure to energy stocks while oil is trading over $100 per barrel? These three stocks provide…

Read more »

investor looks at volatility chart
Metals and Mining Stocks

Gold, Staples, or Cash: Where Should You Put Your Money When Markets Get Rocky?

Long-term success comes from staying diversified and investing through market weakness.

Read more »

Printing canadian dollar bills on a print machine
Dividend Stocks

Transform Your TFSA Into a Cash-Creating Machine With $10,000

These two monthly dividend stocks can deliver stable, reliable passive income.

Read more »

shopper checks her receipt
Dividend Stocks

Canadians Are Spending More Carefully. This Retail Stock Is Built for It.

Here's a retailer that can keep growing even when consumers get cautious.

Read more »

stocks climbing green bull market
Stocks for Beginners

A Year Later: The Growth Stock I’d Still Hold for the Next Decade

This TSX healthcare software acquirer is growing recurring revenue fast and looks built for a 10-year hold.

Read more »